Big Phar­ma joins £200M UK Biobank se­quenc­ing project; Monopar sets terms for $40M IPO

→ The UK Biobank is kick­ing off an am­bi­tious £200 mil­lion project to un­der­take whole-genome se­quenc­ing of 450,000 par­tic­i­pants, prob­ing the role that ge­net­ics plays in a range of com­mon and chron­ic ail­ments in­clud­ing de­men­tia, men­tal ill­ness, can­cer and heart dis­ease. Am­gen, As­traZeneca, Glax­o­SmithK­line and J&J pooled £100 mil­lion to­tal in ex­change for 9 months of ex­clu­sive ac­cess, while The Well­come Trust char­i­ty and the UK gov­ern­ment each pro­vid­ed £50 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER